Southeast Asia Covid-19 Vaccine Tracker: Who Will Get What, When
Bloomberg 12/31/2020 Ian Sayson and Claire Jiao
(Bloomberg) In the race to immunize people against the coronavirus, Singapore has pulled ahead of its neighbors to become the first in Southeast Asia to start an official Covid-19 vaccination program.
The city-state began inoculating healthcare workers on Dec. 30, when it gave shots to 40 staff from its national infectious diseases center.
Indonesia, which was the first in the region to receive a vaccine shipment, needs to wait for more data before approving China’s Sinovac Biotech Ltd. shots for use. Southeast Asia’s biggest and most populous economy has announced multiple agreements to receive potential vaccines as the nation fights the region’s worst coronavirus outbreak.
FinancialBuzz.com’s latest
The Buzz Show: Featuring Our Corporate News Recap on “Arcturus Therapeutics Shares Fall After Analyst Downgrade Stock”
Arcturus Therapeutics
(NASDAQ: ARCT) plunged over 41% after analysts downgraded the company on disappointing results from a Phase 1/2 trial of its COVID-19 vaccine candidate.
Even though the company had been granted approval from the Singapore Health Sciences Authority to move ahead with a Phase 2 study, analysts were worried that the candidate would not be able to achieve competitive levels of vaccine efficacy with single-shot dosing.
Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. is a clinical-stage mRNA medicines and vaccines company with enabling technologies: (i) LUNAR® lipid-mediated delivery, (ii) STARR™ mRNA Technology and (iii) mRNA drug substance along with drug product manufacturing expertise. Arcturus’ diverse pipeline of RNA therapeutic and vaccine candidates includes s
Arcturus Therapeutics to Advance ARCT-032, an Aerosolized LUNAR® mRNA-based Therapeutic, as a Development Candidate for Cystic Fibrosis Lung Disease businesswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesswire.com Daily Mail and Mail on Sunday newspapers.